Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

Similar documents
Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.

DRY EYE and MGD. Contact Central Maryland Eye Associates Today.

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work?

Evidence for Technology in the Treatment of Advanced Dry Eye

Dry Eyes The mucin layer

Dry Eye Syndrome (DES)

Dry Eye. A Closer Look

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

DRY EYE INFORMATION AND TREATMENTS

Dry Eye Disease Update

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary


Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Cataract. What is a Cataract?

HELP HEAL YOUR PATIENTS DRY EYES.

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Precision Focus...From Every Angle. BEFORE & AFTER PRK SURGERY Patient Instruction Booklet.

Welcome. Medical History Do you have any allergies to medications? No Yes If Yes, Please Explain

pat hways Medtech innovation briefing Published: 21 April 2015 nice.org.uk/guidance/mib29

Learn Connect Succeed. JCAHPO Regional Meetings 2017

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Pardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD

Advanced Diagnosis and Management of OSD and Tear Dysfunction

CLINIQUE LASERVUE Informed Consent Form for Photo-Therapeutic Keratectomy (PTK)

Tear Structure. Structure = Stability. Disclosures. In Depth Management of Ocular Surface & Tear Film Disorders UNDERSTANDING THE OCULAR SURFACE

Scottish Dry Eye Guidelines

Setting Your Sight Back on Life.

Precision Focus...From Every Angle. BEFORE & AFTER LASIK SURGERY Patient Instruction Booklet.

Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC

Blepharitis. Information for patients Ophthalmology (Emergency Eye Centre) Large Print

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC

PATIENT REGISTRATION FORM

DISTANCE LEARNING COURSE. Scope of the Eye Care Practice , BSM Consulting All rights reserved.

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)

Cataract. What is a Cataract?

**Continue to Back**

Dry eye syndrome is more likely to affect people who are over the age of 60, and the condition is more common among women than men.

4/20/2014. Building Dry Eye Service Line. Mike Trier. Financial Disclosure. Approach of This Talk. Mike Trier No Financial Interest

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

DATE MRN NAME. J. Everett, MD SAMPLE. Eye Physician & Surgeon Cataract and Refractive Surgery Specialist

No Conflict of Interest to Report Charles Stockwell, O.D

PATIENT REGISTRATION INFORMATION. Please Print

Preferred Name: First Name: Last Name: Middle Initial: Mailing Address: City: State: Zip: Alternate number: address:

ACULAR EYE DROPS 5 mg/ml Eye Drops

Ophthalmology. Ophthalmology Services

FREQUENTLY ASKED QUESTIONS. Frequently Asked Questions

Anatomy: There are 6 muscles that move your eye.

Ocular Jeopardy Marc R. Bloomenstein OD, FAAO

Informed Consent for Excimer Laser Surface Ablation Surgery (PRK, LASEK, epi-lasik, and others)

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

Patient Information Leaflet Glaucoma Procedures. Trabeculectomy

CLINIQUE LASERVUE. Informed Consent Form for Photo-Refractive Keratectomy (PRK)

Thank you very much for choosing us and we look forward to your visit!

Dry Eye Syndrome. A Guide

Understanding the Role of Meibomian Gland Dysfunction in Dry Eyes

World innovation for dry-eye syndrome using Intense Pulsed Light technology

PESSARY INSTRUCTIONS FOR USE

SAMPLE WHAT LASIK CAN DO

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

What are some common conditions that affect the cornea?

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

Microblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS

Dry Eye and Related Corneal Issues. Outline. Dry Eye Syndrome (DES)

The cataract laser technology of tomorrow is here for you today. See inside to learn about all your exciting new options

How is your general health? Circle the response that best describes your state of health.

Information for patients considering cataract surgery Castleton Day Surgery Unit, Yeatman Hospital, Sherborne

PRESCRIBING INFORMATION

Instructions for Patients Following Vitreoretinal Surgery Who Need to Posture

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Patient Information Cataract Surgery

Dry Eye Disease (DED)

LASIK. Lens. Cornea. Iris. Vitreous. Macula. Retina

INFORMED CONSENT FOR CORNEAL COLLAGEN CROSS-LINKING WITH RIBOFLAVIN (C3-R) FOR PATIENTS WITH KERATOCONUS OR CORNEAL ECTASIA

Consulting Bausch+Lomb/Valeant, NovaBay (Avenova), Google, Allergan, Vistakon, Alcon

CONSENT FOR PHOTOTHERAPEUTIC KERATECTOMY (PTK)

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Dr. Mark VanOtterloo DAOM - Licensed Acupuncturist

Patient information. Retinal Detachment Surgery St. Paul s Eye Unit PIF 024 V7

Dry Eye Prescribing Guidelines

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

SOUTHSIDE COMMUNITY ACUPUNCTURE, LLC. Financial Policies

Consent for Cataract Surgery Prepared by Hopewell Lambertville Eye Associates

D RY E YE C LINIC AT THE O FFICE OF D R. D AVID R. F RAZEE

REPORT OF USE TEST UNDER DERMATOLOGIST AND OPHTHALMOLOGIST CONTROL

IPL for the management of MGD/DED. Dr. Jeffrey Judelson, FRCSC

RED EYE, RED EYE What do YOU See???

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Corner on Wellness Chiropractic Center Therapeutic Massage

LETTER OF INFORMATION AND CONSENT FORM

AgePage. Aging And Your Eyes. Steps To Protect Your Eyesight

Vision Health: Conditions, Disorders & Treatments EYELID DISORDERS

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

ZADITEN Eye Drops 1.0%

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

SKABT36v2 Improve The Appearance Of The Skin Using Micro- Dermabrasion

Financial Disclosures

Transcription:

ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you should read this entire notice carefully. Medical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services. You will be responsible for 100% of all fees for each procedure. The following items are NOT covered by any insurance. You are responsible for these charges: Items or Services: Cost: Specialty Dry Eye Testing $189.00 LipiFlow Both Eyes $2200.00 I have read and understand the above statement and agree to pay for all services, and understand that my insurance will not be billed for the procedures listed above. Preliminary and aftercare follow-up visits can be billed to insurance will be billed. I am responsible for any copays and co-insurance and understand that any amounts billed can be applied towards deductibles. Specialty Dry Eye Testing Signature: Date: LipiFlow Signature: Date:

David L. Kading, OD, FAAO, FCLSA Kristi Kading, OD, FAAO, FCOVD Katherine Shen, OD Charissa Young, OD Patient Name: Date: - - Dry Eye Questionnaire How frequently do you experience any of these dry eye symptoms? Never Sometimes Often Constant Dryness, Grittiness or Scratchiness Soreness or Irritation Burning or Watering Eye Fatigue 0 1 2 3 How severe are your dry eye symptoms? No problems Tolerable Uncomfortable Bothersome Intolerable Unable to perform my daily tasks Dryness, Grittiness or Scratchiness Soreness or Irritation Burning or Watering Eye Fatigue 0 1 2 3 4 IN OFFICE USE ONLY BELOW SEG DEQ (SPEED) Score Meiboscale: OD: 0 = 0% 1 = 25% 2 = 25-50% 3 = 50-75% 4 = 75-100% 11830 NE 128 th St. Suite 1, Kirkland, WA 98034 1911 4 th Ave, Seattle, WA 98101 p. 425.821.8900 / f. 425.814.9782 p. 206.622.4828 / f. 206.622.8247

David L. Kading, OD, FAAO, FCLSA Kristi Kading, OD, FAAO, FCOVD Katherine Shen, OD Charissa Young, OD OS: 0 = 0% 1 = 25% 2 = 25-50% 3 = 50-75% 4 = 75-100% 11830 NE 128 th St. Suite 1, Kirkland, WA 98034 1911 4 th Ave, Seattle, WA 98101 p. 425.821.8900 / f. 425.814.9782 p. 206.622.4828 / f. 206.622.8247

Ocular Surface Disease Index (OSDI ) 2 Ask your patient the following 12 questions, and circle the number in the box that best represents each answer. Then, fill in boxes A, B, C, D, and E according to the instructions beside each. HAVE YOU EXPERIENCED ANY OF THE FOLLOWING DURING THE LAST WEEK: All of Most of Half of Some of None of 1. Eyes that are sensitive to light? 4 3 2 1 0 2. Eyes that feel gritty? 4 3 2 1 0 3. Painful or sore eyes? 4 3 2 1 0 4. Blurred vision? 4 3 2 1 0 5. Poor vision? 4 3 2 1 0 Subtotal score for answers 1 to 5 (A) HAVE PROBLEMS WITH YOUR EYES LIMITED YOU IN PERFORMING ANY OF THE FOLLOWING DURING THE LAST WEEK: All of Most of Half of Some of None of 6. Reading? 4 3 2 1 0 N/A 7. Driving at night? 4 3 2 1 0 N/A 8. Working with a computer or bank machine (ATM)? 4 3 2 1 0 N/A 9. Watching TV? 4 3 2 1 0 N/A Subtotal score for answers 6 to 9 HAVE YOUR EYES FELT UNCOMFORTABLE IN ANY OF THE FOLLOWING SITUATIONS DURING THE LAST WEEK: All of Most of Half of Some of None of 10. Windy conditions? 4 3 2 1 0 N/A 11. Places or areas with low humidity (very dry)? 4 3 2 1 0 N/A 12. Areas that are air conditioned? 4 3 2 1 0 N/A (B) Subtotal score for answers 10 to 12 (C) ADD SUBTOTALS A, B, AND C TO OBTAIN D (D = SUM OF SCORES FOR ALL QUESTIONS ANSWERED) TOTAL NUMBER OF QUESTIONS ANSWERED (DO NOT INCLUDE QUESTIONS ANSWERED N/ A) (D) (E) Please turn over the questionnaire to calculate the patient s final OSDI score.

PATIENT INFORMATION FOR LIPIFLOW TREATMENT (Treatment for Meibomian Gland Dysfunction / Evaporative Dry Eye) The information in this document is to help you decide whether or not to have a LipiFlow Treatment. Please carefully read this document in its entirety. Ask your doctor any questions that you may have about the information in this document prior to having a LipiFlow Treatment. INTRODUCTION The surface of the eye is covered in a lining of tears called the tear film. The tear film is made up of three layers: a Lipid (oil) layer which lubricates and prevents evaporation of the tears; an Aqueous (water) layer, which nourishes and protects the eye surface; and a Mucin layer, which adheres to the eye. Since the tear film is exposed directly to the air, the protective lipid layer is essential to maintaining a healthy tear film on the eye. When the protective lipid layer of the tear film is lacking, the eye surface can become irritated and dry eye symptoms can occur. Evaporative Dry Eye is a disease that results from not having enough lipid in the tear film to protect the eye. Evaporative dry eye is most often caused by a blockage or obstruction of the eyelid glands, called the Meibomian Glands, which produce the lipid layer of the tear film. Meibomian Gland Dysfunction is a disease that results from the formation of plugs inside the glands, which obstruct gland openings and limit the lipid secreted by the glands into the tears. WHAT IS THE LIPIFLOW SYSTEM? The LipiFlow System is a medical device used by a doctor to apply heat and pressure to the eyelids to allow the lipids from the blocked eyelid glands to flow into the tear film. Your doctor will determine if the LipiFlow System is an appropriate treatment option you based on a complete exam of your eye health, including evaluation for blocked glands and associated dry eye symptoms. WHAT ARE THE INDICATIONS FOR LIPIFLOW TREATMENT? The LipiFlow System is intended for the application of localized heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye. WHAT ARE ALTERNATIVE TREATMENTS FOR MGD AND EVAPORATIVE DRY EYE? Possible alternative treatments for MGD and evaporative dry eye include: Manual expression of your eyelid glands by your doctor. Warm compress therapy and eyelid hygiene using scrubs and manual massage. Topical prescription medications Over-the-counter tear replacements and lubricants for dry eye. Punctal plugs made of silicone or collagen inserted in the tear ducts. Cauterization (sealing) of the opening of the tear duct in the eye. WHAT SHOULD I EXPECT DURING A LIPIFLOW TREATMENT? The 12-minute treatment will begin with you either resting in a reclined chair or lying comfortably on a table in a procedure room. Your doctor will place 1-2 drops of a mild anesthetic in the eye(s) to be treated. Your doctor will gently fit the LipiFlow (Disposable) eyepiece under your eyelids. You will be asked to close your eyes gently around the eyepiece and keep them closed. The LipiFlow will be activated. You will begin to feel both gentle pressure and warmth on your eyelid. The eyepiece will become gradually warmer on your eyelids. Once the temperature reaches a therapeutic range, the device will maintain this temperature for 2 minutes at a constant pressure. This is when the glands are being brought to the appropriate temperature to begin melting the blockages within the glands. At the end of the 2 minutes, the pressure will be released briefly. Next, the temperature will be maintained but the pressure will go through different modes, including slow increasing pressure and pulsation, for several cycles throughout the remaining 10 minutes of treatment. This is done to facilitate removing the blockages from the glands. WHAT ARE THE CONTRAINDICATIONS OF THE LIPIFLOW TREATMENT? The LipiFlow System should not be used in patients with the following conditions. Use of the device in patients with these conditions may cause injury. Safety and effectiveness of the device have not been studied in patients with these conditions. Ask your doctor if you have any of the following conditions. Recent eye surgery, eye injury or a Herpes infection of the eye of eyelid, or chronic recurrent eye inflammation within the prior 3 months 1

Current eye infection or eye inflammation Eyelid abnormality that affects eyelid function Eye surface abnormality that may affect the integrity of the eye surface WHAT ARE THE PRECAUTIONS REGARDING LIPIFLOW TREATMENT? The eyepiece used for treatment (Disposable) may not fit all eyes, such as eyes with small eyelid anatomy. Use of the LipiFlow System is not recommended in patients with the following conditions. Patients with these conditions may have reduced treatment effectiveness because these conditions may cause eye symptoms unrelated to cystic meibomian glands. Safety and effectiveness of the device have not been studied in patients with these conditions. Ask your doctor if you have any of the following conditions. Moderate to severe allergy in the eye Severe eyelid inflammation. Patients with severe eyelid inflammation should be treated medically prior to device use. Systemic disease conditions that cause dry eye Taking medications known to cause dryness In addition, the treatment procedure may loosen previously inserted punctual plugs, which may worsen the patient s dry eye symptoms. WHAT ARE THE WARNINGS REGARDING LIPIFLOW TREATMENT? You should be aware of the following warnings related to the LipiFlow System. Federal law restricts this device to sale by or on the order of a licensed physician. You should be under direct supervision during the entire length of treatment Remove contact lenses prior to treatment. You can resume contact lens wear one hour after completion of treatment unless there is an adverse effect, as determined by you and your doctor. In the event of an adverse effect such as, eye surface irritation, inflammation or discomfort, your doctor will advise you when to resume contact lens wear following resolution of the effect. Do not to attempt to remove the eyepiece (Disposable) from your eye during treatment Keep your eyelids closed during treatment. If your eyelids are not closed, the eyepiece (Disposable) will not be in the proper position to provide appropriate treatment of your eyelids. In case of discomfort, your doctor can reduce the pressure applied to your eyelids or pause the treatment at any time. WHAT ARE THE RISKS AND POTENTIAL ADVERSE EFFECTS OF THE LIPIFLOW TREATMENT? There is no guarantee that you will receive any medical benefit as a result of the LipiFlow treatment. It is possible that your dry eye symptoms and blocked eyelid glands will improve. It is also possible that your condition will remain the same or worsen. Potential adverse effects that may occur as a result of the procedure include, but are not limited to the onset or increase in: Eyelid or eye pain requiring discontinuation of the treatment procedure; Eyelid irritation or inflammation (for example, eyelid swelling, itching, stye); Eye surface irritation or inflammation (for example, scratch on the eye surface, swelling of the eye surface or eye redness); and Eye symptoms (for example, burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light). Potential serious adverse events that are not anticipated because of the device mitigations to prevent occurrence include: Heat-related injury to the eyelid or eye; Physical pressure-induced injury to the eyelid; and Eye surface infection. In addition, the LipiFlow treatment may involve risks that are unforeseeable. There is always the possibility that you will have an adverse event or problem that is currently unknown and unexpected. You should discuss any questions or concerns you might have with your doctor. If you experience any problems during the treatment, it is important that you tell your doctor. Patient s Name: Signature: Date: 2